Cargando…

Using Next Generation Sequencing to Study the Genetic Diversity of Candidate Live Attenuated Zika Vaccines

Zika virus (ZIKV) is a mosquito-transmitted positive-sense RNA virus in the family Flaviviridae. Candidate live-attenuated vaccine (LAV) viruses with engineered deletions in the 3’ untranslated region (UTR) provide immunity and protection in animal models of ZIKV infection, and phenotypic studies sh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collins, Natalie D., Shan, Chao, Nunes, Bruno T.D., Widen, Steven G., Shi, Pei-Yong, Barrett, Alan D.T., Sarathy, Vanessa V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349499/ https://www.ncbi.nlm.nih.gov/pubmed/32260110 http://dx.doi.org/10.3390/vaccines8020161

Ejemplares similares

Attenuation of Zika Virus by Passage in Human HeLa Cells
por: Li, Li, et al.
Publicado: (2019)

Inter- and intra-lineage genetic diversity of wild-type Zika viruses reveals both common and distinctive nucleotide variants and clusters of genomic diversity
por: Collins, Natalie D., et al.
Publicado: (2019)

A genetically stable Zika virus vaccine candidate protects mice against virus infection and vertical transmission
por: Adam, Awadalkareem, et al.
Publicado: (2021)

Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate
por: Chen, Qi, et al.
Publicado: (2018)

A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage
por: Shan, Chao, et al.
Publicado: (2017)

An attenuated Zika virus NS4B protein mutant is a potent inducer of antiviral immune responses
por: Li, Guangyu, et al.
Publicado: (2019)

Zika vaccine candidates progress through nonclinical development and enter clinical trials
por: Barrett, Alan D T
Publicado: (2016)

Erratum for Chen et al., “Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate”
por: Chen, Qi, et al.
Publicado: (2019)

A single-dose live attenuated chimeric vaccine candidate against Zika virus
por: Chin, Wei-Xin, et al.
Publicado: (2021)

An effective live-attenuated Zika vaccine candidate with a modified 5′ untranslated region
por: Nazneen, Farzana, et al.
Publicado: (2023)

Japanese encephalitis virus live attenuated vaccine strains display altered immunogenicity, virulence and genetic diversity
por: Davis, Emily H., et al.
Publicado: (2021)

Genome Characterization of Yellow Fever Virus Wild-Type Strain Asibi, Parent to Live-Attenuated 17D Vaccine, from Three Different Sources
por: Davis, Emily H., et al.
Publicado: (2021)

Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
por: Barrett, Alan D. T.
Publicado: (2018)

Structural and Nonstructural Genes Contribute to the Genetic Diversity of RNA Viruses
por: Collins, Natalie D., et al.
Publicado: (2018)

Attenuation of Live-Attenuated Yellow Fever 17D Vaccine Virus Is Localized to a High-Fidelity Replication Complex
por: Davis, Emily H., et al.
Publicado: (2019)

Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone
por: Touret, Franck, et al.
Publicado: (2018)

Genetic Diversity Does Not Contribute to Attenuation of HeLa Passaged Wild-Type Yellow Fever Virus Strain French Viscerotropic Virus
por: Strother, Ashley E., et al.
Publicado: (2022)

Peli1 signaling blockade attenuates congenital zika syndrome
por: Luo, Huanle, et al.
Publicado: (2020)

A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity
por: Zou, Jing, et al.
Publicado: (2018)

Rational Development of Live-Attenuated Zika Virus Vaccines
por: Adam, Awadalkareem, et al.
Publicado: (2023)

Developing Zika vaccines: the lessons for disease X
por: Barrett, Alan D. T.
Publicado: (2018)

Preparing for the next Zika
por: Hoyt, Kendall, et al.
Publicado: (2016)

Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models
por: Shukla, Rahul, et al.
Publicado: (2020)

Research and development of Zika virus vaccines
por: Dawes, Brian E, et al.
Publicado: (2016)

Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine
por: Giel-Moloney, Maryann, et al.
Publicado: (2018)

Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal models
por: Piras-Douce, Fabienne, et al.
Publicado: (2021)

Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone
por: Li, Xiao-Feng, et al.
Publicado: (2018)

A Novel Live-Attenuated Vaccine Candidate for Mayaro Fever
por: Weise, William J., et al.
Publicado: (2014)

Vector- and Rodent-borne Diseases in Europe and North America: Distribution, Public Health Burden and Control
por: Barrett, Alan D.T.
Publicado: (2007)

Vaccines in the Tropics
por: Barrett, Alan D.T.
Publicado: (2011)

A systematic approach to the development of a safe live attenuated Zika vaccine
por: Kwek, Swee Sen, et al.
Publicado: (2018)

Overview of Zika virus (ZIKV) infection in regards to the Brazilian epidemic
por: Slavov, S.N., et al.
Publicado: (2016)

Zika structural genes determine the virulence of African and Asian lineages
por: Nunes, Bruno T. D., et al.
Publicado: (2020)

Zika Virus: A New Therapeutic Candidate for Glioblastoma Treatment
por: Francipane, Maria Giovanna, et al.
Publicado: (2021)

Fractional Dosing of Yellow Fever Live Attenuated 17D Vaccine: A Perspective
por: Hansen, Clairissa A, et al.
Publicado: (2023)

AIDS, Avian flu, SARS, MERS, Ebola, Zika… what next?
por: Reperant, Leslie A., et al.
Publicado: (2017)

Identification of the flavivirus conserved residues in the envelope protein hinge region for the rational design of a candidate West Nile live-attenuated vaccine
por: Maloney, Bailey E., et al.
Publicado: (2023)

2138. Evaluating the Safety and Immunogenicity of the rZIKV/D4Δ30-713 Live Attenuated Chimeric Zika Candidate Vaccine in Healthy Flavivirus-Naïve Adults
por: Zhong, Diana, et al.
Publicado: (2022)

Identification of a Live Attenuated Vaccine Candidate for Tularemia Prophylaxis
por: Mahawar, Manish, et al.
Publicado: (2013)

A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions
por: Liu, Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a0r2c9k775cugcg4tl9508e83b